Ppardelta agonist 5, an orally active PPARdelta-selective agonist (EC50=0.335 µM), is much greater than that of the prototypical standard GW0742. Ppardelta agonist 5 promotes improvements in bone density and microarchitecture in vivo[1].
Molecular Weight:
446.49
Formula:
C23H21F3N2O2S
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
